EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enzyme‐Directed and Organelle‐Specific Sphere‐to‐Fiber Nanotransformation Enhances Photodynamic Therapy in Cancer Cells

Shenglong Gan, Liu Yang, Yiyuan Heng, Qingxin Chen, Dongqing Wang, Jie Zhang, Wenyu Wei, Zhiyang Liu, Demian Ifeanyi Njoku, Jian Lin Chen, Yi Hu, Hongyan Sun iD

Small Methods · 2024

DOI: 10.1002/smtd.202301551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2024. Verfasst von Shenglong Gan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and COSDAF (Centre of Super-Diamond and Advanced Films) City University of Hong Kong, Hong Kong, 999077, China. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Reactive Oxygen Species, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Excellent Young Scientists Fund of China, Research Grants Council of Hong Kong, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Employing responsive nanoplatforms as carriers for photosensitizers represents an effective strategy to overcome the challenges associated with photodynamic therapy (PDT), including poor solubility, low bioavailability, and high systemic toxicity. Drawing inspiration from the morphology transitions in biological systems, a general approach to enhance PDT that utilizes enzyme‐responsive nanoplatforms is developed. The transformation of phosphopeptide/photosensitizer co‐assembled nanoparticles is first demonstrated into nanofibers when exposed to cytoplasmic enzyme alkaline phosphatase. This transition is primarily driven by alkaline phosphatase‐induced changes of the nanoparticles in the hydrophilic and hydrophobic balance, and intermolecular electrostatic interactions within the nanoparticles. The resulting nanofibers exhibit improved ability of generating reactive oxygen species (ROS), intracellular accumulation, and retention in cancer cells. Furthermore, the enzyme‐responsive nanoplatform is expanded to selectively target mitochondria by mitochondria‐specific enzyme sirtuin 5 (SIRT5). Under the catalysis of SIRT5, the succinylated peptide/photosensitizer co‐assembled nanoparticles can be transformed into nanofibers specifically within the mitochondria. The resulting nanofibers exhibit excellent capability of modulating mitochondrial activity, enhanced ROS formation, and significant anticancer efficacy via PDT. Consequently, the enzyme‐instructed in situ fibrillar transformation of peptide/photosensitizers co‐assembled nanoparticles provides an efficient pathway to address the challenges associated with photosensitizers. It is envisaged that this approach will further expand the toolbox for enzyme‐responsive biomaterials for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsReactive Oxygen SpeciesNanoparticlesMitochondriaHumansNanofibersCell Line, TumorNeoplasmsAnimalsAlkaline PhosphataseSirtuins

Stichwörter der Autor:innen

PDTenzymenanotransformationorganelleself‐assembly

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesAlkaline PhosphataseSirtuins

Autor:innen und Institutionen

  • Department of Chemistry and COSDAF (Centre of Super-Diamond and Advanced Films) City University of Hong Kong, Hong Kong, 999077, China.
  • Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, 518057, China.
  • College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, 410083, China.
  • Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Universi…
  • Department of Applied Science, Hong Kong Metropolitan University, Ho Man Tin, Kowloon, Hong Kong, 999077, China.
  • State Key Laboratory of Complex, Severe, and Rare Diseases, Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Beijing, 100730, China.

ORCID-Profile: Hongyan Sun

Förderung

  • National Natural Science Excellent Young Scientists Fund of China
  • Research Grants Council of Hong Kong
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Gan, S., Yang, L., Heng, Y., Chen, Q., Wang, D., Zhang, J., Wei, W., Liu, Z., Njoku, D. I., Chen, J. L., Hu, Y., & Sun, H. (2024). Enzyme‐Directed and Organelle‐Specific Sphere‐to‐Fiber Nanotransformation Enhances Photodynamic Therapy in Cancer Cells. Small Methods. https://doi.org/10.1002/smtd.202301551

Vancouver

Gan S, Yang L, Heng Y, Chen Q, Wang D, Zhang J, et al. Enzyme‐Directed and Organelle‐Specific Sphere‐to‐Fiber Nanotransformation Enhances Photodynamic Therapy in Cancer Cells. Small Methods. 2024. doi:10.1002/smtd.202301551

BibTeX
@article{Gan2024,
  author = {Gan, Shenglong and Yang, Liu and Heng, Yiyuan and Chen, Qingxin and Wang, Dongqing and Zhang, Jie and Wei, Wenyu and Liu, Zhiyang and Njoku, Demian Ifeanyi and Chen, Jian Lin and Hu, Yi and Sun, Hongyan},
  title = {Enzyme‐Directed and Organelle‐Specific Sphere‐to‐Fiber Nanotransformation Enhances Photodynamic Therapy in Cancer Cells},
  journal = {Small Methods},
  year = {2024},
  doi = {10.1002/smtd.202301551}
}
Kostenlos starten →